Aurobindo Pharma Limited (BOM:524804)
India · Delayed Price · Currency is INR 1,685.00
-5.00 (-0.30%)
At close: Oct 7, 2026
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 971.12 billion as of October 7, 2026. Its market cap has increased by 52.49% in one year.
Market Cap
971.12B
Enterprise Value
945.92B
Revenue
349.35B
Global Rank
n/a
Country Rank
n/a
PE Ratio
26.24
ChartMarket Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 971.12B, an increase of 10,012.36%. That is a compound annual growth rate of 20.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 971.12B | 41.34% |
| Dec 31, 2025 | 687.09B | -11.35% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.81T |
| Dr. Reddy's Laboratories | 999.66B |
| Lupin | 927.73B |
| Abbott India | 570.16B |
| GlaxoSmithKline Pharmaceuticals | 470.02B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 203.39B |
| Caplin Point Laboratories | 200.09B |